Reverse transcriptase in oncogenic RNA virion may play a critical role in the integration of viral genomes into host cell DNA and viral tumorigenesis1,2). The specific inhibitor against the enzyme might be a candidate for the chemotherapeutic agent of viral oncogenesis. Thus, we have been screening for Streptomyces metabolites inhibiting reverse transcriptase of avian myeloblastosis virus (AMV) and reported the inhibitor, named retrostatin, in the previous paper". In the course of screening for the enzyme inhibitors, the precipitate of the broth filtrate of Isolate H 1180 MY-18 at acidic pH showed strong inhibition against the enzyme. The active component was purified by silica gel column chromatography and the free acid of the inhibitor was recovered as a red amorphous powder. The molecular formula and physicochemical properties of the inhibitor were identical with those of limocrocin4,5). Limocrocin was reported as the pigment produced by Streptotnyces limosus. Since biological activity of limocrocin had not been reported in the literatures, we studied the inhibitory activities of limocrocin against various kinds of DNA and RNA polymerases. The results are described in this paper.
Materials Purified reverse transcriptase of AMV (specific activity: 50,000 u/mg protein) was obtained from Life Science Inc. DNA-directed DNA polymerase I of Escherichia coli, DNA-directed RNA polymerase of E. coli (400 u/vial), DNA-directed DNA polymerase of calf thymus (50 u/vial), calf thymus DNA, poly-(rA) and oligo-(dT)12-18 were products of P. The method reported by NISHIo et al. 3 ) was modified to determine reverse transcriptase activity as described below: An assay solution was composed of 80 mm Tris-HCI buffer (pH 8.0), 5 mm MgCI2, 60 mm NaCI, 6 mm dithiothreitol, 0.02 mm [3H]TTP (12.5 pCi/ml), poly-(rA) (4 pg/ ml), oligo-(dT)12--18 (200 ng/ml), bovine serum albumin (200 pg/ml) and reverse transcriptase of AMV (2.0 u/ml). A test sample was dissolved in 20 mm Tris-HC1 buffer (pH 8.0) to prepare a test solution. A mixture of the assay solution (50 pl) and the test solution (50 pl) was incubated at 37°C for 1 hour and the incubation was terminated by cooling in an ice bath. The resulting mixture was soaked into a 2.4 cm-round piece of filter paper previously treated with 0.1 M pyrophosphate solution and dried. The filter paper was washed three times with 10% TCA, subsequently washed once with ethanol and dried. The radioactivity of the acid insoluble fraction remaining on the filter paper was measured in a toluene-based scintillation cocktail.
Assay Method to Determine DNA-Directed DNA Polymerase Activity
The method reported by RICHARDSON et al.6) was modified to determine DNA-directed DNA polymerase activity as described below: An assay solution was composed of 80 ms glycineNaOH buffer (pH 9.2), 10 mm MgCl2, 1.4 mm dithiothreitol, 40RM each of dATP, dCTP, dGTP and [3H]TTP (0.70 ItCi/ml), activated calf thymus DNA (50 pg/ml), yeast RNA (200 pg/ml) and DNA-directed DNA polymerase I of E. coli (12.5 u/ml) or calf thymus DNA-directed DNA polymerase (30.0 u/ml). A mixture of the assay solution (50 pl) and the test sample dissolved in 20 mat glycine-NaOH buffer (pH 9.2, 50 PI) was incubated at 37'C for 30 minutes and the resulting mixture was treated with the same procedures described above to measure the radioactivity of the acid insoluble fraction. Assay Method to Determine DNA-Directed RNA Polymerase Activity DNA-Directed RNA polymerase activity was determined as described below: An assay solution was composed of 80 ms Tris-HC1 buffer (pH 7.9), 20 mM MgCI2 0.2 mm EDTA, 0.2 mm dithiothreitol, 0.8 mM K2HPO4 0.3 mm each of ATP, CTP and GTP, 0.03 mm [3H]UTP (0.32 pCi/ ml), bovine serum albumin (1.0 mg/ml), calf thymus DNA (0.3 mg/ml) and DNA-directed RNA polymerase of E. coli (180 u/ml). A mixture of the assay solution (50 id) and the test sample dissolved in 20 mm Tris-HCI buffer (pH 7.9) was incubated at 37°C for 10 minutes and the resulting mixture was treated with the same procedures described above to measure the radioactivity of the acid insoluble fraction.
The antimicrobial activity was determined by the agar dilution method on glucose nutrient agar and the inhibitor (=limocrocin) showed very weak antimicrobial activity against only a few of Gram-positive bacteria as seen in Table 1 . Both limocrocin and adriamycin showed 50 inhibition against reverse transcriptase of AMV at a concentration of about 50 Itg/ml, as seen in Fig. 1 . ID50 of adriamycin against DNAdirected DNA or RNA polymerase of E. coli or DNA-directed DNA polymerase of calf thymus was less than 50 itg/ml. Nevertheless, ID50 of limocrocin against those polymerases were more than 100 pg/ml. The inhibitory activity of limocrocin against reverse transcriptase of AMV was not affected by changing of concentration of the template-primer, the substrate or the carrier protein, but significantly reduced when the concentration of reverse transcriptase of AMV was increased, as seen in Table 2 . Thus, limocrocin was considered to be a specific enzyme inhibitor against reverse transcriptase of AMV.
To date, adriamycin7), daunomycin7), strep- Limocrocin was used at a concentration of 50 pg/ml.
